Breadcrumb
AMCP Submits Comments on Draft CY2018 Medicare Part B Physician Fee Schedule Urging CMS to Critically Evaluate Coding & Reimbursement Options Under Part B to Ensure Patient Access and Affordability of Biologics and Biosimilars, Require Documentation of P
9/11/17